Nishanth Ulhas Nair - Concepedia

Author

Nishanth Ulhas Nair

National Institutes of Health ORCID

Also Known As

Danielle Leach, Nair, Nishanth, Nair, Nishanth Ulhas, Nishanth Nair, Nishanth U. Nair, Nishanth Ulhas Nair

154

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Cancer Institute University of Maryland, College Park Center for Cancer Research Sungkyunkwan University

About

Nishanth Ulhas Nair is an author at National Institutes of Health specializing in health sciences, engineering, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	5	5	273
2	Engineering	4	4	87
3	Medicine	4	4	347
4	Natural Sciences	1	1	85
5	Biology	1	1	85

Nishanth Ulhas Nair

Publications

982

Citations

H-Index

Page 1

	Year	Citations
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis Nandini Verma, Yaron Vinik, Ashish Saroha, Science Advances	2020	167
Synthetic lethality-mediated precision oncology via the tumor transcriptome Joo Sang Lee, Nishanth Ulhas Nair, Gal Dinstag, Cell Tumor BiologyHealth SciencesTumor HeterogeneityMedicineCancer Genomics	2021	153
Genome-Wide Evaluation of Histone Methylation Changes Associated with Leaf Senescence in Arabidopsis Judy A. Brusslan, Ana M. Rus Alvarez-Canterbury, Nishanth Ulhas Nair, PLoS ONE Senescent ArabidopsisEpigenetic ChangeGeneticsGenome-wide EvaluationGenomics	2012	85
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors Sanju Sinha, Rahulsimham Vegesna, Sumit Mukherjee, Nature Cancer Tumor BiologyTumor HeterogeneityMedicineSingle Cell SequencingCancer Genomics	2024	71
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein Amir Kedan, Nandini Verma, Ashish Saroha, Cell Death and Disease	2018	66
A landscape of response to drug combinations in non-small cell lung cancer Nishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, Nature Communications	2023	52
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome Gal Dinstag, Eldad D. Shulman, Efrat Elis, Med	2022	39
ChIPnorm: A Statistical Method for Normalizing and Identifying Differential Regions in Histone Modification ChIP-seq Libraries Nishanth Ulhas Nair, Avinash Sahu, Philipp Bücher, PLoS ONE Histone ModificationsStatistical MethodEngineeringEpigenetic ChangeGenetics	2012	38
Migration rather than proliferation transcriptomic signatures are strongly associated with breast cancer patient survival Nishanth Ulhas Nair, Avinash Das, Vasiliki-Maria Rogkoti, Scientific Reports	2019	37
Discovery of Targets for Immune–Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha Avinash Sahu, Xiaoman Wang, Phillip Munson, Cancer Discovery	2023	36

Page 1